1. Home
  2. RGEN vs LCID Comparison

RGEN vs LCID Comparison

Compare RGEN & LCID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • LCID
  • Stock Information
  • Founded
  • RGEN 1981
  • LCID 2007
  • Country
  • RGEN United States
  • LCID United States
  • Employees
  • RGEN N/A
  • LCID N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • LCID Auto Manufacturing
  • Sector
  • RGEN Health Care
  • LCID Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • LCID Nasdaq
  • Market Cap
  • RGEN 8.0B
  • LCID 8.1B
  • IPO Year
  • RGEN N/A
  • LCID N/A
  • Fundamental
  • Price
  • RGEN $127.47
  • LCID $2.16
  • Analyst Decision
  • RGEN Buy
  • LCID Hold
  • Analyst Count
  • RGEN 12
  • LCID 9
  • Target Price
  • RGEN $170.40
  • LCID $3.00
  • AVG Volume (30 Days)
  • RGEN 694.0K
  • LCID 140.8M
  • Earning Date
  • RGEN 07-29-2025
  • LCID 08-04-2025
  • Dividend Yield
  • RGEN N/A
  • LCID N/A
  • EPS Growth
  • RGEN N/A
  • LCID N/A
  • EPS
  • RGEN N/A
  • LCID N/A
  • Revenue
  • RGEN $650,429,000.00
  • LCID $870,140,000.00
  • Revenue This Year
  • RGEN $13.93
  • LCID $76.52
  • Revenue Next Year
  • RGEN $14.35
  • LCID $95.37
  • P/E Ratio
  • RGEN N/A
  • LCID N/A
  • Revenue Growth
  • RGEN 4.88
  • LCID 40.67
  • 52 Week Low
  • RGEN $102.97
  • LCID $1.93
  • 52 Week High
  • RGEN $182.52
  • LCID $4.43
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 54.11
  • LCID 48.77
  • Support Level
  • RGEN $121.44
  • LCID $1.98
  • Resistance Level
  • RGEN $131.43
  • LCID $2.23
  • Average True Range (ATR)
  • RGEN 4.47
  • LCID 0.10
  • MACD
  • RGEN 0.61
  • LCID 0.01
  • Stochastic Oscillator
  • RGEN 74.57
  • LCID 70.97

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

Share on Social Networks: